VLA1701

· Valneva Austria GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VLA1701, covering 2021-04-23 to 2021-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Study Confirming A Human Challenge Model and Investigating The Safety Of VLA1701 [Phase 2]